Curi Bio offers fully characterized, quality-guaranteed iPSC-derived cell models for sale or licensing to support drug discovery, disease modeling, and translational research. Select models include isogenic pairs for controlled comparative studies. For research use only.
iPSC-derived myoblast lines spanning healthy donors, patient-derived disease models, and CRISPR-corrected isogenic pairs — for DMD, DM1, and XLMTM research.
iPSC-derived cardiomyocyte lines for cardiac disease modeling and translational studies, including a CRISPR-corrected isogenic pair for hypertrophic cardiomyopathy.
Motor neuron and neuromuscular junction media systems are available today. iPSC-derived motor neuron cell lines — including a ChR2-optogenetic line — are in development for the Fall 2026 launch.
Licensing Only
30 curated iPSC lines representing North American genetic diversity. Ideal for population disease modeling, pharmacogenomics, and evaluating varied drug responses.
